Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive Myelofibrosis

Tatyana A. Petukhova, Danielle Tartar, Karen Mayo, Maxwell A Fung, Joseph Tuscano, Jared Jagdeo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Erythema nodosum (EN) is a panniculitis frequently encountered secondary to medical therapy. We present a case of a 66-year-old gentleman with JAK2-positive myelofibrosis who developed transient EN-like lesions on his trunk and upper and lower extremities approximately three weeks after starting lenalidomide therapy. The subcutaneous nodules improved with intralesional triamcinolone and topical clobetasol without discontinuation of lenalidomide.

J Drugs Dermatol. 2016;15(8):1024-1025.

Original languageEnglish (US)
Pages (from-to)1024-1025
Number of pages2
JournalJournal of drugs in dermatology : JDD
Volume15
Issue number8
StatePublished - Aug 1 2016

Fingerprint

Janus Kinase 2
Panniculitis
Erythema Nodosum
Primary Myelofibrosis
Clobetasol
Triamcinolone
Lower Extremity
Therapeutics
Pharmaceutical Preparations
lenalidomide

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology

Cite this

@article{a96fadb0867a4ccdbac213a0ebb91ebe,
title = "Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive Myelofibrosis",
abstract = "Erythema nodosum (EN) is a panniculitis frequently encountered secondary to medical therapy. We present a case of a 66-year-old gentleman with JAK2-positive myelofibrosis who developed transient EN-like lesions on his trunk and upper and lower extremities approximately three weeks after starting lenalidomide therapy. The subcutaneous nodules improved with intralesional triamcinolone and topical clobetasol without discontinuation of lenalidomide. J Drugs Dermatol. 2016;15(8):1024-1025.",
author = "Petukhova, {Tatyana A.} and Danielle Tartar and Karen Mayo and Fung, {Maxwell A} and Joseph Tuscano and Jared Jagdeo",
year = "2016",
month = "8",
day = "1",
language = "English (US)",
volume = "15",
pages = "1024--1025",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "8",

}

TY - JOUR

T1 - Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive Myelofibrosis

AU - Petukhova, Tatyana A.

AU - Tartar, Danielle

AU - Mayo, Karen

AU - Fung, Maxwell A

AU - Tuscano, Joseph

AU - Jagdeo, Jared

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Erythema nodosum (EN) is a panniculitis frequently encountered secondary to medical therapy. We present a case of a 66-year-old gentleman with JAK2-positive myelofibrosis who developed transient EN-like lesions on his trunk and upper and lower extremities approximately three weeks after starting lenalidomide therapy. The subcutaneous nodules improved with intralesional triamcinolone and topical clobetasol without discontinuation of lenalidomide. J Drugs Dermatol. 2016;15(8):1024-1025.

AB - Erythema nodosum (EN) is a panniculitis frequently encountered secondary to medical therapy. We present a case of a 66-year-old gentleman with JAK2-positive myelofibrosis who developed transient EN-like lesions on his trunk and upper and lower extremities approximately three weeks after starting lenalidomide therapy. The subcutaneous nodules improved with intralesional triamcinolone and topical clobetasol without discontinuation of lenalidomide. J Drugs Dermatol. 2016;15(8):1024-1025.

UR - http://www.scopus.com/inward/record.url?scp=85021389278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021389278&partnerID=8YFLogxK

M3 - Article

C2 - 27538006

AN - SCOPUS:85021389278

VL - 15

SP - 1024

EP - 1025

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 8

ER -